Specific translational studies include: Molecular mechanisms of migration contribute to metastasis and subsequently thought to be central to the cancer progression
poor clinical outcome for cancer patients.
Not exact matches
«This is the first national study to identify specific regions of the United States where residents may be at an increased risk
for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.
Small cell lung cancer (SCLC) accounts
for 14 percent of all lung cancers and is often rapidly resistant to chemotherapy resulting in
poor clinical outcomes.
Intended primarily
for use by patients
for whom loss of muscle mass (sarcopenia) may contribute to
poor clinical outcomes in chronic illness and decreased quality of life.